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Uniquely expressed in the colon, MS4A12 exhibits store-
operated Ca2+ entry (SOCE) activity. However, compared to 
MS4A1 (CD20), a Ca2+ channel and ideal target for successful 
leukaemia immunotherapy, MS4A12 has rarely been studied. 
In this study, we investigated the involvement of MS4A12 
in Ca2+ influx and expression changes in MS4A12 in human 
colonic malignancy. Fluorescence of GCaMP-fused MS4A12 
(GCaMP-M12) was evaluated to analyse MS4A12 activity in 
Ca2+ influx. Plasma membrane expression of GCaMP-M12 
was achieved by homo- or hetero-complex formation 
with no-tagged MS4A12 (nt-M12) or Orai1, respectively. 
GCaMP-M12 fluorescence in plasma membrane increased 
only after thapsigargin-induced depletion of endoplasmic 
reticulum Ca2+ stores, and this fluorescence was inhibited by 
typical SOCE inhibitors and siRNA for Orai1. Furthermore, 
GCaMP-MS4A12 and Orai1 co-transfection elicited greater 
plasma membrane fluorescence than GCaMP-M12 co-
transfected with nt-M12. Interestingly, the fluorescence of 
GCaMP-M12 was decreased by STIM1 over-expression, while 
increased by siRNA for STIM1 in the presence of thapsigargin 
and extracellular Ca2+. Moreover, immunoprecipitation 
assay revealed that Orai1 co-expression decreased protein 
interactions between MS4A12 and STIM1. In human colon 
tissue, MS4A12 was expressed in the apical region of the 
colonic epithelium, although its expression was dramatically 
decreased in colon cancer tissues. In conclusion, we propose 
that MS4A12 contributes to SOCE through complex 
formation with Orai1, but does not cooperate with STIM1. 
Additionally, we discovered that MS4A12 is expressed in 
the apical membrane of the colonic epithelium and that its 
expression is decreased with cancer progression.
Keywords: colon cancer, GCaMP, MS4A12, Orai1, STIM1, 
store-operated Ca2+ entry 
INTRODUCTION
The MS4A (membrane-spanning 4-domain family, subfamily 
A) gene family contains 18 members in humans (Liang and 
Tedder, 2001; Zuccolo et al., 2010), and their encoded pro-
teins show tissue-specific expression (Liang and Tedder, 2001; 
Zuccolo et al., 2010; 2013). CD20 (MS4A1) is specifically ex-
pressed only in B cells and is a highly selective cancer marker 
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for B cell lymphoma (Herter et al., 2013; Reff et al., 1994). 
Ca2+ influx of CD20 is activated by the binding of anti-CD20 
monoclonal antibody (mAb) (Beers et al., 2010; Bubien et 
al., 1993), which is unique as a successful surface target of 
mAbs (Walshe et al., 2008). These features have enabled the 
production of blockbuster antibodies, anti-CD20 antibodies, 
which have greatly contributed to the success of the biophar-
maceutical industry (Rogers et al., 2014). Additionally, CD20 
has been shown to have store-operated Ca2+ influx activity (Li 
et al., 2003; Vacher et al., 2015). As an analogue to CD20, 
the MS4A family member MS4A12, a colon-specific mem-
brane protein, has also been found to exhibit tissue-specific 
expression and store-operated Ca2+ influx activity (Koslowski 
et al., 2008). However, characteristics of the Ca2+ channel 
activity of MS4A12 are unclear, and the potential of MS4A12 
as a colon cancer marker is controversial.
 Store-operated Ca2+ entry (SOCE) is a major Ca2+ entry 
pathway in the epithelia (Prakriya and Lewis, 2015; Sobra-
dillo et al., 2014; Villalobos et al., 2017; Yuan et al., 2007). 
Among ion channels, SOCE channels have unique biophysical 
properties and regulation modes. The core uniqueness is reg-
ulation by STIM protein, the only known endoplasmic retic-
ulum (ER) Ca2+ sensor until now (Prakriya and Lewis, 2015). 
Orai channels are representative SOCE channels regulated 
by STIM protein, the only known ER Ca2+ sensor identified 
to date (Prakriya and Lewis, 2015). STIM1 is located in the 
ER membrane and senses Ca2+ contents in the ER (Kim and 
Muallem, 2011; Prakriya and Lewis, 2015; Yuan et al., 2007). 
Once activated by Ca2+ store depletion, STIM1 proteins un-
dergo conformational changes in their EF domain and then 
oligomerize and accumulate in puncta near the plasma mem-
brane to gate the Orai1 channel (Feske et al., 2006; Wang 
et al., 2010). Other proteins also play a key role in SOCE 
channels that historically have SOC channel activity, such as 
TRPC1. Dynamic assembly of a TRPC1-STIM1-Orai1 ternary 
complex is involved in activation of Ca2+ entry, and this is a 
common molecular basis for SOC and CRAC channels (Ong 
et al., 2007; Sabourin et al., 2015). On the other hand, the 
pore component of L-type Ca2+ channel CaV1.2 is inhibited 
by over-expression of STIM1 (Park et al., 2010; Wang et al., 
2010), and Orai1 increases the proximity of STIM1 to CaV1.2 
(Wang et al., 2010). Reportedly, over-expression of MS4A12 
increased Ca2+ permeability via thapsigargin, and the ob-
served permeability decreased when MS4A12 expression was 
knock-downed by siRNA (Koslowski et al., 2008). However, 
MS4A12 has not been investigated as an SOCE channel reg-
ulated by Orai1 and STIM1.
 Tumour cells exhibit distinct and acquired traits that are 
relevant to or influenced by changes in Ca2+ handling (Mon-
teith et al., 2007; Parekh, 2010; Roderick and Cook, 2008). 
MS4A12 was first reported to show increased expression in 
patients with colon cancer (Koslowski et al., 2008). However, 
recent reports have indicated that MS4A12 is predominantly 
expressed in normal colon tissues and tends to show de-
creased expression when transformed into cancerous tissues 
(Dalerba et al., 2011; Drew et al., 2014; Roberts et al., 2015). 
Although the direction of changes in expression during 
cancer progression is unclear, MS4A12 is a promising colon 
cancer marker for predicting both cancer diagnosis and pro-
gression (Dalerba et al., 2011; Drew et al., 2014; Koslowski 
et al., 2008).
 GCaMP fluorescence proteins are robust tools with which 
to monitor Ca2+ concentrations nearby ion channels (Aker-
boom et al., 2013; Ko et al., 2017; Nguyen et al., 2020). In-
deed, multiple gating states and oscillation of Orai1 has been 
documented by genetically encoded Ca2+-indicators for opti-
cal imaging fused to the N-terminal of Orai1 protein (Dynes 
et al., 2016), and lysosomal Ca2+ efflux has been successfully 
measured by GCaMP3-tagged TRPML1 (Shen et al., 2012). 
In this study, we evaluated SOCE activity for MS4A12 based 
on Orai1 and STIM1 interactions. We used GCaMP6s fused 
with MS4A12 to measure Ca2+ influx near MS4A12 and to 
test hetero-complex formation with Orai1. Additionally, ex-
pression changes of MS4A12, as well as Orai1 and STIM1, 
were observed in normal and cancer tissues from the human 
colon.
MATERIALS AND METHODS
Clones, cell lines, materials, and human colon samples
pCMV-SPORT6-MS4A12 clones (long isotype of hM-
S4A12) were purchased from Korea Human Gene Bank 
(hMU004204), and 3X flag-MS4A12 was sub-cloned into 
pCMV5 vectors using NotI/BamHI site. pLenti6.3-GCaMP6s-
MS4A12 was produced using BamHI/SpeI sites for GCaMP6s 
and SpeI/XhoI sites for MS4A12 into pLenti6.3 vectors. C-term 
truncated MS4A12 was produced by insertion of a stop 
codon by mutagenesis at the 224th amino acid. Truncation 
mutants of STIM1 and STIM1D76A were described in a previous 
study (Yuan et al., 2007). Flag-Orai1 was kindly provided by 
Shmuel Muallem. Thapsigargin (T9033), 2-APB (D9754), and 
BTP2 (YM-58483) were purchased from Sigma (USA). An-
ti-MS4A12 antibody (HPA057657) and anti-flag (9E10) anti-
body were purchased in Sigma. Anti-myc antibody (2276s), 
anti-GOK/STIM1 antibody (610954), anti-Orai1 antibody 
(ACC-062), and ZO-1 antibody (ab190085) were purchased 
from Cell Signaling Technology (USA), BD Bioscience (USA), 
Alomone (Israel), and Abcam (UK), respectively. Aldolase A 
(N-15, sc-12059; Santa Cruz Biotechnology, USA) and β-actin 
(sc-1616; Santa Cruz Biotechnology) were used, and an-
ti-mouse, anti-rabbit, or anti-goat IgG conjugated with Alexa 
Fluor 488, 563 (Invitrogen, USA) was utilized as secondary an-
tibody. Anti-mouse, anti-rabbit, or anti-goat IgG conjugated 
with HRP was purchased form Thermo Fisher Scientific (USA). 
Plasmids were transiently transfected into HEK293 cells using 
Lipofectamine 2000 (Invitrogen) and T84 cells using ExGen 
500 (Thermo Fisher Scientific). siRNA was transfected with 
RNAimax (Invitrogen). HEK293, A549, and CaCo2 cells were 
maintained in DMEM-High Glucose (Invitrogen). T84 cells 
were maintained in a 1:1 mixture of Ham’s F-12 medium and 
DMEM (Invitrogen). H508 and HT29 cells were maintained 
in RPMI1640. All media were supplemented with 10% fetal 
bovine serum (Invitrogen), penicillin (50 IU/ml), and strepto-
mycin (50 μg/ml). The experiments using human colon and 
cancer tissue samples were approved by the Institutional Re-
view Board of Severance Hospital, Yonsei University College 
of Medicine, Seoul, Korea (IRB protocols No. 4-2014-0349). 
Normal tissues were obtained from tumor margins under 
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inspection by an oncology surgeon. All subjects provided writ-
ten informed consent, and their clinicopathologic information 
are outlined in Supplementary Table S1.
Plasma expression of GCaMP-MS4A12
HEK cells were transfected with GCaMP-MS4A12 alone and 
GCaMP-MS4A12 with untagged MS4A12 or Flag tagged 
Orai1 (plasmid 1:1 ratio) using Lipofectamine 2000, and 
were grown on glass coverslips. After growing for 36 h, the 
cells were stimulated with 1 μM thapsigargin in 5 mM Ca2+ 
regular solution for 5 min. Then, cells on coverslips were fixed 
with 4% paraformaldehyde in phosphate-buffered saline and 
mounted on slide glass. Images were obtained with a Zeiss 
LSM 780 confocal microscope (Zeiss, Germany).
Ca2+ influx measurement using GCaMP6s-MS4A12
No-tagged MS4A12 (nt-M12) and GCaMP-MS4A12 plas-
mids were mixed at a 1:1 ratio and then transfected into 
HEK293 cells grown on coverslips. In case of Orai-GCaMP-
MS4A12 hetero complex, flag-tagged Orai1 was used 
instead of nt-M12. At 48 h after transfection, changes in 
GCaMP fluorescence were assessed using a Zeiss 780 con-
focal microscope (Zeiss). siRNA of Orai1 and STIM1 was 
also transfected 1 day before MS4A12 transfection. During 
fluorescence measurements, cells were continually perfused 
with a Ca2+ free regular solution (37°C) containing 150 mM 
NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM glucose, and 10 mM 
HEPES at pH 7.4 with NaOH. Thapsigargin of 5 μM was used 
for stimulation and store depletion, after which 5 mM Ca2+ 
regular solution was perfused to visualize Ca2+ influx-induced 
fluorescence of GCaMP-MS4A12. To inhibit SOCE mediated 
Ca2+ influx, 5 μM 2-aminoethoxydiphenyl borate (2-APB) 
was treated during the measurement, and 500 nM BTP2 was 
pre-treated 5 min before starting the measurement. Ca2+ in-
flux activity was calculated according to changes in GCaMP6s 
fluorescence (ΔF) at each time point over basal fluorescence 
(F0; ΔF/F0). Averages ΔF/F0 of all measurements were ob-
tained from more than three independent experiments (each 
comprising analyses of 4-20 cells).
Immunoprecipitation and Western blot analysis
For immunoprecipitation assay, HEK293 cells transfected with 
appropriate plasmid were lysed with sonication in lysis buffer 
(150 mM NaCl, 5 mM Na-EDTA, 10% glycerol, 20 mM Tris-
HCl [pH 8.0], 0.5% Triton X-100, and proteinase inhibitors 
[Complete; Roche Applied Science, USA]). To capture the 
protein, appropriate antibody was incubated for more than 4 
h, after which protein A/G beads were added to capture an-
tibody bound protein complex. Beads were washed with 400 
μl of lysis buffer four times, and 2× sample buffer was used 
to elute whole protein complexes. For Western blot analysis, 
cells were lysed in lysis buffer, and lysates were separated on 
4% to 12% pre-made gradient sodium dodecyl sulfate-poly-
acrylamide electrophoresis gels (Koma Biotech, Korea) and 
transferred to membranes. For tissue experiments, human 
colon and cancer tissue were homogenized with lysis buffer 
after chopping them into small pieces. Appropriate antibod-
ies were used to detect the proteins, and HRP-conjugated 
secondary antibody and ECL solution (Amersham Bioscience, 
UK) were used for detection by chemi-luminescence. Quan-
tification of band intensity was performed using MultiGauge 
software (Fujifilm, Japan).
Reverse transcription polymerase chain reaction
Total RNA was extracted using TRIzol reagent (Invitrogen), 
and an equal amount of RNA from each sample was re-
verse-transcribed to cDNA using Superior Script II Reverse 
transcriptase (Enzynomics, Korea). The cDNA was amplified 
with specific primers and a Taq polymerase (2X TOPsim-
ple Premix; Enzynomics). The polymerase chain reaction 
(PCR) primer sequences were as follows: hMS4A12 sense, 
ACA TTG CCC TGG GGG GTC TTC T; hMS4A12 antisense, 
CCA GAA ATG GCA GCA AAG AGG CT (205 bp); hSTIM1 
sense, GGAAGACCTCAATTACCATGAC; hSTIM1 antisense, 
GCTCCTTAGAGTAACGG TTCTG (440 bp); hOrai1 sense, 
ACC TGC ATC CTG CCC AAC ATC; hOrai1 antisense, GCC 
CAG GCC AGC TCG ATG TG (107 bp); β actin-sense, GAC 
CCA GAT CAT GTT TGA GAC C; β-actin antisense, GGC CAT 
CTC CTG CTC GAA GTC; 18s ribosome sense, GTGGAGC-
GATTTGTCTGGTT; and 18s ribosome anti-sense, CGCTGAG-
CCAGTCAGTGTAG (199 bp).
Statistical analysis
Data are presented as the mean ± SEM. Statistical analysis 
was performed with Student’s t-tests, ANOVA, followed 
by Tukey’s multiple comparison, or one-way ANOVA using 
GraphPad Prism software (ver. 5.0; GraphPad Software, 
USA), as appropriate. P values ≤ 0.05 were considered statis-
tically significant.
RESULTS
Characteristics of MS4A12 as a store-operated Ca2+ influx 
channel
To measure Ca2+ influx near MS4A12, GCaMP-MS4A12 
(GCaMP-M12) was constructed by fusing MS4A12 with the 
GCaMP6s Ca2+ indicator, which fluoresces in response to a 
short-term Ca2+ concentration increase near MS4A12. How-
ever, GCaMP-M12 did not reach the cell membrane, likely 
due to the high solubility of GCaMP. HEK cells expressing 
GCaMP-M12 alone showed fluorescence throughout the 
cytosol when stimulated with thapsigargin in 5 mM Ca2+ 
solution (Fig. 1A). This problem was overcome by co-express-
ing GCaMP-M12 with nt-M12 at a 1:1 DNA transfecting 
ratio: GCaMP-M12 co-transfected with nt-M12 showed 
plasma membrane localization in the same thapsigargin 
condition (Fig. 1B). Successful plasma membrane localization 
proved that GCaMP-M12 complexed with nt-M12. Next, we 
evaluated the pharmacological characteristics of MS4A12 
store-dependent Ca2+ influx using plasma membrane local-
ized GCaMP-M12. First, we confirmed the spontaneous Ca2+ 
influx of MS4A12 (Fig. 1C). When 5 mM Ca2+ was perfused 
without stimulation, we observed no fluorescence increases 
in GCaMP-M12. However, when cells were stimulated with 
a store-depleting condition (5 μM thapsigargin for 5 min 
in the 5 mM Ca2+ extracellular solution), the fluorescence 
of GCaMP-M12 very rapidly and greatly increased (Fig. 1D, 
Supplementary Movie S1). Additionally, the increased fluo-
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rescence of GCaMP-M12 by store-depleting condition was 
inhibited by 2 mM 2-APB (Fig. 1E, Supplementary Movie S2). 
Furthermore, pre-treatment with 500 nM of BTP2 (Fig. 1F) 
completely blocked any florescence increases in the store-de-
pleting condition.
 Both the robust increase in GCaMP-M12 fluorescence 
under the thapsigargin and external 5 mM Ca2+ condition 
and the lack of fluorescence changes upon thapsigargin-in-
duced internal Ca2+ efflux clearly demonstrated that the 
increased fluorescence of GCaMP-M12 occurred as a result 
of increased Ca2+ concentrations near GCaMP-M12 or in-
creased Ca2+ influx through MS4A12 in plasma membrane. 
Accordingly, thapsigargin-dependent Ca2+ influx and its 
blockade by typical SOCE inhibitors revealed that the com-
plex of GCaMP-M12 with nt-M12 monitors or functions as a 
store-operated Ca2+ influx pore.
Orai1 co-expression increases and Orai1 knockdown 
decreases thapsigargin-induced increases in GCaMP-M12 
fluorescence
Measuring Ca2+ influx in Fura2-AM loaded HEK cells, we 
noted that over-expression of MS4A12 elicited increased 
thapsigargin-activated Ca2+ influx, which was further in-
creased by STIM1 co-expression (Supplementary Fig. S1). 
Fig. 1. GCaMP-M12 complexes with nt-M12 localized in plasma membrane, and its fluorescence is dependent on store-operated 
Ca2+ influx. (A and B) Localization of GCaMP-M12 in HEK cells upon confocal microscopy. The transmembrane domain of MS4A12 is 
indicated by blue rods, and GCaMP and Ca2+ are indicated by green and red dots, respectively. GCaMP-M12 fluorescence after treatment 
with 1 μM thapsigargin (TG) and extracellular 5 mM Ca2+ (left) and cell boundaries (differential interference contrast [DIC] image, right) 
were observed. Cytosolic localization of GCaMP-M12 expressed alone (A) or co-expressed with nt-M12 (B). Scale bars = 10 μm. (C-G) 
Fluorescence of GCaMP-M12 (green) to detect Ca2+ influx nearby MS4A12. Fluorescence changes in GCaMP6s (ΔF at each time point 
over basal fluorescence [F0; ΔF/F0]) were traced. Average ΔF/F0 of all measurements was obtained from three independent experiments 
(each analysing 4-20 cells). The first and last images in each row show the before and last scene of recording, respectively. The dotted 
outlined cell in the first image indicates cells expressing GCaMP-M12, and the last scene image was merged with the transmission image 
(bar, 20 μm) to show the state of cell fluorescence. (C) Spontaneous Ca2+ influx when extracellular 5 mM Ca2+ was applied without 
any stimulation. (D) To induce store depletion, 5 μM thapsigargin was added, and 5 mM Ca2+ was extracellularly added to allow Ca2+ 
influx. No changes were observed in most cells upon thapsigargin treatment, after which 5 mM Ca2+ evoked increased GCaMP-M12 
fluorescence. (E) 5 μM 2-APB was added to test whether the increased 5 mM Ca2+ with thapsigargin evoked Ca2+ influx was blocked. (F) 
500 nM BTP2 was pre-incubated to block Ca2+ influx through Orai1 before performing B. (G) A summary of Ca2+ influx activity in (C-F).
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However, since the magnitude thereof was much smaller 
than STIM1 effects on Orai1, we presumed that the reason 
why MS4A12 showed characteristics of SOCE might be that 
MS4A12 could hetero-complex with Orai1. Also, STIM1 
could control Orai1 gating, resulting in Ca2+ influx through 
the hetero-complex of MS4A12 and Orai1. To investigate 
Fig. 2. Orai1 knockdown decreases, while co-expression with Orai1 increases, thapsigargin (TG)- and Ca2+-dependent increases 
in GCaMP-M12 fluorescence. (A) Plasma membrane localization of GCaMP-M12 by co-expression with Orai1, similar to that by co-
expression with nt-M12. (B and C) Thapsigargin- and Ca2+-dependent fluorescence changes in GCaMP-M12 under Orai1-co-expression. 
(B) Thapsigargin- and Ca2+-dependent fluorescence changes in GCaMP-M12 co-expressed with Flag-Orai1 and summary in (C). **P ≤ 
0.01. (D-G) Thapsigargin- and Ca2+-dependent fluorescence changes in GCaMP-M12 upon Orai1 knockdown (co-expressed with nt-
M12). Images of each indicated time point (D) and fluorescence changes (F) for thapsigargin- and Ca2+-dependent GCaMP-M12 co-
transfected with nt-MS4A12 in scramble and siOrai1-transfected cells. Summary is in (G). *P ≤ 0.05. siRNA efficiency of Orai1 protein 
was confirmed by Western blot with Orai1-specific antibody (E). (H) Immunoprecipitation assay to observe protein-protein interactions for 
MS4A12 and Orai1. Flag and GFP antibodies were used to detect Orai1 and MS4A12, respectively. Anti-Flag antibody for Orai1 was used 
in immunoprecipitation for GCaMP-M12. (I) Co-localization of GCaMP-M12 and mCherry-Orai1 observed by live cell imaging in normal 
and thapsigargin-stimulated conditions. Scale bars = 10 μm.
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the role of Orai1 in the SOCE-like behaviour of MS4A12, we 
observed the plasma membrane expression of GCaMP-M12 
co-transfected with Flag-tagged Orai1 in its N-terminal (Flag-
Orai1). As when co-expressed with nt-M12 (Figs. 1A and 
1B), the fluorescence of GCaMP-M12 was observed at the 
plasma membrane when co-expressed with Flag-Orai1, 
implying that GCaMP-M12 complexes with Flag-Orai1 (Fig. 
2A). Next, we compared changes in fluorescence upon 
thapsigargin-induced Ca2+ influx between GCaMP-M12 
with nt-M12 and GCaMP-M12 with Flag-Orai1. Interest-
ingly, the relative fluorescence changes were significantly 
higher for GCaMP-M12 co-transfected with Flag-Orai1 than 
for GCaMP-M12 co-transfected with nt-M12 (Figs. 2B and 
2C). Additionally, we examined thapsigargin-induced Ca2+ 
influx-mediated fluorescence changes for GCaMP-M12 
co-expressed with nt-M12 after employing siRNA for Orai1 
(siOrai1). In siOrai1 treatment, increases in GCaMP-M12 
fluorescence were delayed, and the degree of fluorescence 
increase was reduced (Figs. 2D-2G). To prove protein inter-
actions between MS4A12 and Orai1, immunoprecipitation 
experiments were performed, in doings so, we found that 
GCaMP-M12 indeed interacted with Flag-Orai1 and that 
their interaction was enhanced upon thapsigargin treatment. 
Moreover, GCaMP-M12 and Orai1 interactions were con-
firmed by live cell imaging using GCaMP-M12 and mCher-
ry-Orai1 expressed HEK cells (Fig. 2H). Therein, both proteins 
co-localized at the plasma membrane, and their co-localiza-
tion was enhanced by thapsigargin treatment (Fig. 2I). Alto-
gether, these results demonstrated that MS4A12 complexes 
with Orai1 and that the Ca2+ influx activity of MS4A12 is de-
pendent on Orai1.
STIM1 co-expression decreases and STIM1 knockdown 
increases thapsigargin-induced increases in GCaMP-M12 
fluorescence
Next, we examined the effects of STIM1on the SOCE-like 
behaviour of MS4A12. To do so, GCaMP-M12 with nt-M12 
expressing cells were co-expressed with STIM1 via pIRES2 
DsRED vector (expresses STIM1 and DsRED fluorescent pro-
teins separately) to distinguish between STIM1-expressing 
red fluorescent cells (yellow dotted line cells, Fig. 3A) and 
non-expressing non-fluorescent cells (white dotted line 
cells, Fig. 3A). Cells expressing STIM1 showed significantly 
reduced changes in GCaMP-M12 fluorescence(Figs. 3B and 
3C), compared to cells not expressing STIM1 (white dotted 
line cells, Figs. 3D). Meanwhile, when STIM1 expression was 
decreased with siRNA against STIM1 (siSTIM1), the fluores-
cence of GCaMP-M12 complexed with nt-M12 was more 
intense (Figs. 3D-3G). This was an unexpected and very com-
pelling result, and implied that Ca2+ influx through MS4A12 
is inhibited by STIM1 co-expression. In immunoprecipitation 
experiments, Flag-MS4A12 with myc-STIM1 showed protein 
interaction in normal conditions, and this interaction was 
slightly enhanced by thapsigargin (Fig. 3H). In addition, im-
munoprecipitation using each truncated protein showed that 
the cytosolic C terminal region (amino acids 225 to 267) of 
MS4A12 interacts with the CCD2+3, C2+3 region of STIM1 
(STIM1-Orai activating region [SOAR] of STIM1) (Figs. 3I and 
3J, Supplementary Fig. S2). Next, to examine the effect of 
Orai1 on the binding of STIM1D76A (constitutive active form) 
with MS4A12, Orai1 was over-expressed, and the binding 
strength of STIM1D76A with MS4A12 was observed (Fig. 3K). 
Interestingly, MS4A12 binding to STIM1D76A was reduced by 
Orai1 over-expression. These results indicated that STIM1 
might face competitive in the presence of Orai1. Immu-
nostaining for MS4A12 and STIM1 revealed that these two 
proteins are closely localised at some region and that, even 
in a normal state, thapsigargin treatment did not elicit big 
large changes in their co-localization (Fig. 3L). Overall, these 
data suggested that MS4A12 is not a canonical SOCE chan-
nel directly regulated by STIM1, because Ca2+ influx through 
MS4A12 is inhibited by STIM1 and because MS4A12 binding 
to STIM1D76A is inhibited by Orai1 over-expression.
Apical expression of MS4A12 in human colonic crypts and 
polarised T84 cells decreases in colon cancer malignancy
The expression of MS4A12 in colon cancer is controversial 
(Dalerba et al., 2011; Drew et al., 2014; Koslowski et al., 
2008). We compared the expression levels of MS4A12 and 
Orai1 in samples from patients with colon cancer and colon 
cancer cell lines using RT-PCR and quantitative PCR (Figs. 4A 
and 4B). H508, CaCO-2, and HT29 cells, human adenocar-
cinoma cell lines originating from the colon, were used to 
examine mRNA expression levels of MS4A12. A549 cells, a 
human adenocarcinoma originating from the lung, was used 
as a negative control of MS4A12 expression. All three colon 
cancer cell lines, as well as A549 cells, showed no MS4A12 
mRNA expression, whereas Orai1 showed high mRNA ex-
pression. In addition, MS4A12 expression was significantly 
lower in the cancer tissue than normal tissue (margins of co-
lon cancers) from surgically removed specimens from colon 
cancers patient (described in Supplementary Table S1), which 
indicated that the expression of MS4A12 decreases during 
cancerous transformation. Moreover, we examined protein 
integrity and expression levels in normal and cancer tissue 
lysates (Fig. 4C). MS4A12 protein was clearly observed in 
normal colon tissue lysates, but significantly decreased in can-
cer tissue lysates. Accordingly, we deemed that protein and 
mRNA expression of MS4A12 is decreased in cancer states of 
the human colon and that MS4A12 expression is normal in 
the human colon protein, not a colon cancer marker.
DISCUSSION
MS4A12 was reported as a store-operated Ca2+ channel 
(Koslowski et al., 2008). However, no studies have examined 
the specific molecular mechanisms of the store-operated Ca2+ 
channel function of MS4A12. Our study demonstrated that 
the store-operated Ca2+ influx activity of MS4A12 is driven by 
a hetero-complex formed by MS4A12 and Orai1. The plasma 
membrane localization of GCaMP-M12 by co-expression of 
nt-MS4A12 or flag-Orai1 indicates that the hydrophobicity re-
quired for the membrane insertion is achieved by homo (with 
nt-M12; Fig. 1A)- or hetero (with Flag-Orai1; Figs. 2A and 
2B)-complex formation with GCaMP-M12. Immunoprecipita-
tion and co-localization of MS4A12 and Orai1 confirmed that 
MS4A12 interacts with Orai1 and that their interaction is fur-
ther enhanced by thapsigargin (Figs. 2H and 2I). Interestingly, 
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STIM1 co-expression inhibited thapsigargin-activated increas-
es in fluorescence for GCaMP-M12 complexed with nt-M12 
(Figs. 3A-3G), and this was recovered by siSTIM1 treatment. 
In addition, Flag-Orai1 co-expression decreased MS4A12 pro-
tein interactions with STIM1 (Fig. 3K). Altogether, these data 
imply that MS4A12 contributes to store-operated Ca2+ influx 
via complex formation with Orai1. However, given the inhib-
ited store-operated Ca2+ influx upon STIM1 over-expression, 
MS4A12 seems to be a non-canonical component protein for 
store-operated Ca2+ influx.
 The characteristic of MS4A12 as a store-operated Ca2+ 
channel only when it forms a hetero-complex with Orai1 is 
similar to that of TRPC3, which store-operated Ca2+ influx 
activity dependent on TRPC1 (Yuan et al., 2007). However, 
TRPC3 does not bind to STIM1 directly. In this regard, the 
relationship between MS4A12 and STIM1 is different from 
Fig. 3. STIM1 overexpression inhibits thapsigargin (TG)- and Ca2+-dependent increases in GCaMP-M12 fluorescence, and interaction 
between MS4A12 and STIM1 are reduced by Orai1. (A-C) Thapsigargin- and Ca2+-dependent fluorescence changes GCaMP-M12 
(co-expressed with nt-M12) in a STIM1 overexpressed condition. (A) Images at each indicated time point. STIM1 co-expressed cells 
are indicated by yellow dotted lines, and non-STIM1-expressing cells are indicated by white dotted lines. (B) Traces of fluorescence 
changes. Summary is in (C). ***P ≤ 0.001. (D-G) Thapsigargin- and Ca2+-dependent fluorescence changes in GCaMP-M12 (with nt-
M12) under a STIM1 knockdown condition. siRNA efficiency for STIM1 was confirmed by Western blot with STIM1-specific antibody. 
(F) The fluorescence change traces. Summary is in (G). **P ≤ 0.01. (H) MS4A12 whole protein interaction with STIM1WT in normal and 
thapsigargin-treated conditions. (I) Truncated MS4A12, in which the intracellular c-terminal region was deleted, shows failed protein-
protein interaction with STIM1. (J) Truncated STIM1 proteins were used to detect the MS4A12 interacting region of STIM1. (K) MS4A12 
interaction with STIM1D76A was decreased by Orai1 over-expression, while STIM1D76A interacted with Orai1. (L) MS4A12 (red) and STIM1 
(green) localization in normal and thapsigargin conditions of HEK293 cells analyzed by immunostaining. White arrows indicate their co-
localized region. Scale bars = 10 μm.
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that between TRPC3 and STIM1, in that MS4A12 can bind to 
STIM1, but their binding is competitively inhibited by Orai1. 
Additional observations are necessary to determine the phys-
iological situation in which MS4A12 forms a hetero-complex 
with Orai1.
 The locations of MS4A12, STIM1, and Orai1 appear to 
differ in cancer tissue and normal tissue (Supplementary 
Fig. S2). The apical major localization of MS4A12 in normal 
colon tissue (Supplementary Fig. S2A) was not observed in 
cancer tissues (Supplementary Fig. S2B). In addition, STIM1 
and Orai1 localization changed in cancer tissue. Most of all, 
in cancer tissue, MS4A12 was nearly completely diminished, 
as seen in Western blot analysis (Fig. 4C). Considering the 
contribution of aberrant ion channel localization during can-
cer progression, such as CaV1.2 in colon cancer (Wang et al., 
2000) and TRPM8 in prostate cancer (Monteith et al., 2007; 
Thebault et al., 2005), the altered location of Orai1 and 
STIM1, as well as the disappearance of MS4A12, may con-
tribute to cancer progression.
 Given that anti-CD20 monoclonal antibodies are effective 
immune-therapeutics for human malignancies, other MS4A 
family members have been identified as potential targets for 
therapeutic intervention (Koslowski et al., 2008; Liang and 
Tedder, 2001). However, MS4A12 is unlikely to be useful 
as a colon cancer-specific target for cancer immunotherapy 
because its expression is mostly eradicated during cancer 
transformation (Fig. 4). Whether MS4A12 can be used as a 
colon cancer immunotherapy target with Ca2+ influx function 
should be reconsidered. Rather, the decreased expression 
of MS4A12 may be a marker of poor prognosis (Dalerba et 
al., 2011; Drew et al., 2014). Based on our results showing 
reduced expression in cancer tissues, it is necessary to further 
investigate the role of MS4A12 under normal colon condi-
tions and the effect of decreased MS4A12 expression on 
the malignant processes of colon cancer. In the meantime, 
we have identified another colon-expressed MS4A member, 
MS4A8, that shows increased expression upon cancer transi-
tion. However, this protein does not appear to be expressed 
in the plasma membrane according to immunocytochemistry 
data using MS4A8 over-expressing cells and live cell imaging 
of mCherry tagged-MS4A8 (Supplementary Fig. S3).
 In conclusion, we suggest that MS4A12 is not a STIM1-reg-
ulated canonical store-operated Ca2+ influx channel and 
shows store-operated Ca2+ influx activity when it forms a het-
ero-complex with Orai1. Additionally, our results indicate that 
MS4A12 is a colon protein marker and that its expression is 
decreased during cancerous states.
Note: Supplementary information is available on the Mole-
cules and Cells website (www.molcells.org).
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Fig. 4. Decreased mRNA and protein expression of MS4A12 in colon cancer. (A) mRNA expression of hMS4A12 and hOrai1 in normal 
and tumour tissue from patients with colon cancer and a human colon cancer cell line. 18s rRNA expression to indicate cDNA levels 
and integrity in each sample. N indicates normal and T indicates tumour regions of colon specimens. (B) Decreased hMS4A12 and 
increased hOrai1 mRNA expression in cancer tissue analysed by quantitative PCR (Q-PCR). ***P ≤ 0.001 compared to normal. (C) Protein 
expression of MS4A12 in normal and cancer tissues. Actin was used as a loading control. Flag-MS4A12 plasmid expressing HEK lysate 
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